← Back
$STOK All transactions

Stoke Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$22K

Shares

605

Price

$37

Filed

Mar 17

Insider

Name

LEVIN ARTHUR A

Title

CIK

0001181556

Roles

Director

Transaction Details

Transaction Date

2026-03-13

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

4,237

Footnotes

The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2025.

Filing Info

Accession No.

0001181556-26-000005

Form Type

4

Issuer CIK

0001623526

LEVIN ARTHUR A's History

Date Ticker Type Value
2026-03-13 STOK $22K
2026-02-27 RNAM D
2026-02-27 RNAM D
2026-02-27 RNAM D
2026-02-27 RNAM D
2026-02-27 RNAM D
2026-02-27 RNAM D
2026-02-27 RNAM D
2026-01-21 RNA $127K
2025-12-31 STOK M $0

Other Insiders at STOK (90d)

Insider Bought Sold Last
SMITH IAN F
Chief Executive Officer
2026-02-17
Kaye Edward M. MD 2026-03-15
TZIANABOS ARTHUR
Interim Executive Chair
$174K 2026-03-10
Hoitt Jason
Chief Patient Officer
$119K 2026-03-18
Leggett Thomas
Chief Financial Officer
$147K 2026-03-18
Krainer Adrian R. $1.6M 2026-03-10
Ticho Barry
CHIEF MEDICAL OFFICER
$517K 2026-04-01
Kahn Clare 2026-04-03
Allan Jonathan
GENERAL COUNSEL & CORP SEC
$599K 2026-03-20